Friday 6 November 2026
Export CAH’s income statement to Excel — free account
Cardinal Health, Inc.
CAH Healthcare Medical Distribution
Cardinal Health, Inc.’s revenue for fiscal 2026 (year ended June 2026) was $254.2 billion, up 14.2% from fiscal 2025.
- Revenue
- +5.47%
- EPS
- +26.3%
- Free cash flow
- +10.9%
- Total debt
- −2.40%
Quarter to September 2026, against a year earlier
267.66
5.73
+2.19%
Follow CAH
Alert me
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 From the 10-Q filed 5 Nov | |
|---|---|---|---|---|---|
Piotroski F-Score |
+8 more TTM periods Free account |
6 | 6 | 7 | — |
| (59.14%) | (68.05%) | (63.98%) | (64.96%) | ||
| 3.16% | 2.92% | 3.10% | 3.17% | ||
ROIC |
44.60% | 62.64% | 125.05% | 246.17% | |
Return on Tangible Assets |
(137.70%) | (155.97%) | (80.85%) | (77.79%) | |
Average Days of Receivables |
20.38 | 19.87 | 19.83 | 20.59 | |
Free Cash Flow per Share |
23.46 | 18.79 | 19.31 | 0.00 | |
Free Cash Flow |
5,536.00 | 4,416.00 | 4,556.00 | — | |
Capital Expenditures |
(563.00) | (586.00) | (618.00) | — | |
| Other line items | |||||
Cash ROIC |
60.81% | 43.37% | 41.35% | 0.00% | |
Accounts Receivable Turnover |
18.80 | 19.06 | 18.79 | 18.21 | |
Accounts Payable Turnover |
6.70 | 6.83 | 6.70 | 6.37 | |
Inventory Turnover |
12.73 | 14.13 | 14.33 | 13.78 | |
Average Days of Payables |
60.41 | 57.22 | 57.16 | 60.32 | |
Days of Inventory on Hand |
31.16 | 27.24 | 25.82 | 27.11 | |
Tax Rate |
(0.26) | (0.23) | (0.22) | (0.20) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
2.46% | 2.53% | 2.52% | 0.00% | |
Share Based Compensation of Revenue |
0.15% | 0.18% | 0.14% | 0.15% | |
Interest Coverage |
8.02 | 6.74 | 7.51 | — | |
Operating CF/Net income |
3.67 | 3.22 | 3.02 | 0.00 | |
Depreciation/Fixed assets |
0.31 | 0.32 | 0.32 | 0.32 | |
Capex/Depreciation |
(0.64) | (0.63) | (0.65) | 0.00 | |
Revenue per Share |
1,036.75 | 1,066.96 | 1,077.32 | 1,111.00 | |
Operating CF per Share |
25.84 | 21.29 | 21.92 | 0.00 | |
Capex per Share |
(2.39) | (2.49) | (2.62) | 0.00 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 |
Columns are period end dates · fundamentals updated 5 Nov 2026